Cysteine proteases of parasitic organisms

Molecular and Biochemical Parasitology

Volumn 120, Issue 1, 2002, Pages 1-21

  Sajid, M ^a   McKerrow, J H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Biological function; Chemotherapy; Classification; Cysteine protease; Evolution; Excystment and serodiagnostics; GPI:protein transamidase; Immunoevasion; Legumain like; Nutrition; Occluding loop; Papain family; pH; Protease trafficking; Protein processing; S2 pocket; Tissue and cell invasion

Indexed keywords

AMIDINOTRANSFERASE; ANTIPARASITIC AGENT; ASPARAGINE DERIVATIVE; AVENIN; CATHEPSIN; CATHEPSIN B; CRUZIPAIN; CYSTEINE PROTEINASE; ENZYME INHIBITOR; K11777; PAPAIN; UNCLASSIFIED DRUG; VACCINE;

CATABOLISM; CELL INVASION; CHEMOTHERAPY; DIRECTED MOLECULAR EVOLUTION; DISEASE MARKER; DRUG TARGETING; ENZYME ACTIVITY; ENZYME LOCALIZATION; ENZYME SPECIFICITY; ENZYME STABILITY; ENZYME STRUCTURE; ENZYME SUBSTRATE; HOST; IMMUNOGENICITY; NONHUMAN; PARASITE; PH; PHYLOGENY; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN PROCESSING; REVIEW; SEQUENCE HOMOLOGY; SERODIAGNOSIS;

EID: 0036178381     PISSN: 01666851     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-6851(01)00438-8     Document Type: Review

References (107)

1. Parasite proteinases and amino acid metabolism: Possibilities for chemotherapeutic exploitation
2. Parasite proteases
3. The proteases and pathogenicity of parasitic protozoa
4. Cysteine protease inhibitors as chemotherapy for parasitic infections
5. Proteinases and associated genes of parasitic helminths
6. Development of cysteine protease inhibitors as chemotherapy for parasitic diseases: Insights on safety, target validation, and mechanism of action
7. Classification of peptidases
8. Development of cysteine protease inhibitors as chemotherapy for parasitic diseases: Insights on safety, target validation, and mechanism of action
9. Cysteine protease inhibitors as chemotherapy: Lessons from a parasite target
10. Revised definition of substrate binding sites of papain-like cysteine proteases
11. Evolutionary families of peptidases
12. Evolution of cysteine proteinases in eukaryotes
13. Lysosomal cysteine proteases: More than scavengers
14. Alignment/phylogeny of the papain superfamily of cysteine proteases
15. Identification of a cDNA encoding an active asparaginyl endopeptidase of Schistosoma mansoni and its expression in Pichia pastoris
16. Asparaginyl endopeptidase activity in adult Schistosoma mansoni
17. Leishmania mexicana mutants lacking glycosylphosphatidylinositol (GPI):protein transamidase provide insights into the biosynthesis and functions of GPI-anchored proteins
18. Soluble GPI8 restores glycosylphosphatidylinositol anchoring in a trypanosome cell-free system depleted of lumenal endoplasmic reticulum proteins
19. Two distinct gene subfamilies within the family of cysteine protease genes
20. The refined 2.15 A X-ray crystal structure of human liver cathepsin B: The structural basis for its specificity
21. Inhibition of trypanosomal cysteine proteinases by their propeptides
22. A primitive enzyme for a primitive cell: The protease required for excystation of Giardia
23. Expression and alteration of the S2 subsite of the Leishmania major cathepsin B-like cysteine protease
24. Crystal structures of human procathepsin B at 3.2 and 3.3 Angstroms resolution reveal an interaction motif between a papain-like cysteine protease and its propeptide
25. The occluding loop in cathepsin B defines the pH dependence of inhibition by its propeptide
26. Role of the occluding loop in cathepsin B activity
27. Biological importance of glycosylation
28. Observing proteases in living cells
29. Lysosomal cysteine protease, cathepsin H, is targeted to lysosomes by the mannose 6-phosphate-independent system in rat hepatocytes
30. Protease trafficking in two primitive eukaryotes is mediated by a prodomain protein motif
31. Processing and trafficking of cysteine proteases in Leishmania mexicana
32. Regulation of the activity of lysosomal cysteine proteinases by pH-induced inactivation and/or endogenous protein inhibitors, cystatins
33. Biochemical properties of purified cathepsin B from Schistosoma mansoni
34. Characterization of native and recombinant falcipain-2, a principal trophozoite cysteine protease and essential hemoglobinase of Plasmodium falciparum
35. Cysteine protease inhibitors block schistosome hemoglobin degradation in vitro and decrease worm burden and egg production in vivo
36. Antimalarial effects in mice of orally administered peptidyl cysteine protease inhibitors
37. Functional expression of falcipain, a Plasmodium falciparum cysteine proteinase, supports its role as a malarial hemoglobinase
38. Comparison of efficacies of cysteine protease inhibitors against five strains of Plasmodium falciparum
39. Inhibition of a Plasmodium vinckei cysteine proteinase cures murine malaria
40. Synthesis and antimalarial effects of phenothiazine inhibitors of a Plasmodium falciparum cysteine protease
41. Antimalarial effects of vinyl sulfone cysteine proteinase inhibitors
42. Proteases involved in erythrocyte invasion by the malaria parasite: Function and potential as chemotherapeutic targets
43. A subtilisin-like protein in secretory organelles of Plasmodium falciparum merozoites
44. Maturation and specificity of Plasmodium falciparum subtilisin-like protease-1, a malaria merozoite subtilisin-like serine protease
45. Peptide derivatives specific for a Plasmodium falciparum proteinase inhibit the human erythrocyte invasion by merozoites
46. Plasmodium falciparum: Protease inhibitors and inhibition of erythrocyte invasion
47. Expression and characterisation of Plasmodium falciparum acidic basic repeat antigen expressed in Escherichia coli
48. Effect of calpain inhibitors on the invasion of human erythrocytes by the parasite Plasmodium falciparum
49. Purification and identification of a neutral endopeptidase in Plasmodium falciparum schizonts and merozoites
50. Plasmodium berghei and Plasmodium chabaudi: A neutral endopeptidase in parasite extracts and plasma of infected animals
51. Purification of a Plasmodium berghei neutral endopeptidase and its localization in merozoite
52. Looking for the exit: How do malaria parasites escape from red blood cells?
53. Plasmodium knowlesi: Studies on invasion of rhesus erythrocytes by merozoites in the presence of protease inhibitors
54. Identification of three stage-specific proteinases of Plasmodium falciparum
55. A cysteine protease activity from Plasmodium falciparum cleaves human erythrocyte ankyrin
56. From the cover: Malaria parasite exit from the host erythrocyte: A two-step process requiring extraerythrocytic proteolysis
57. Protective immunity induced in Aotus monkeys by a recombinant SERA protein of Plasmodium falciparum: Further studies using SERA 1 and MF75.2 adjuvant
58. Immunogenicity and antigenicity of a Plasmodium falciparum protein fraction (90-110 kDa) able to protect squirrel monkeys against asexual blood stages
59. Production of recombinant SERA proteins of Plasmodium falciparum in Escherichia coli by using synthetic genes
60. Effects of hormones and cysteine protease modulators on infection of HepG2 cells by Plasmodium berghei sporozoites in vitro determined by ELISA immunoassay
61. Inhibitors of the major cysteinyl proteinase (GP57/51) impair host cell invasion and arrest the intracellular development of Trypanosoma cruzi in vitro
62. Analysis of the roles of cysteine proteinases of Leishmania mexicana in the host-parasite interaction
63. Oligopeptidase B-dependent signaling mediates host cell invasion by Trypanosoma cruzi
64. Cysteine proteinases and the pathogenesis of amebiasis
65. New concepts regarding the pathogenesis of amebiasis
66. Thiol proteinase expression and pathogenicity of Entamoeba histolytica
67. Naegleria fowleri: Characterization of a secreted histolytic cysteine protease
68. Trichomonad invasion of the mucous layer requires adhesins, mucinases, and motility
69. Biochemistry of the coccidia
70. Proteolytic cleavage of surface proteins enhances susceptibility of lymphocytes to invasion by Theileria parva sporozoites
71. Characterization of a cysteine proteinase from Taenia crassiceps cysts
72. Proteolytic activity of the Gymnorhynchus gigas plerocercoid: Purification and properties of a collagenase from the crude extract
73. An unusual host-parasite relationship: The growth hormone-like factor from plerocercoids of spirometrid tapeworms
74. Nutritional adaptations to parasitism within the platyhelminthes
75. A cysteine proteinase in the cercariae of Diplostomum pseudospathaceum (Trematoda, Diplostomatidae)
76. Excystment of Paragonimus westermani metacercariae by endogenous cysteine protease
77. Cloning of a cysteine protease required for the molting of Onchocerca volvulus third stage larvae
78. Dirofilaria immitis: Proteases produced by third- and fourth-stage larvae
79. Proteases as therapeutic targets
80. The partial characterization of proteases present in the excretory/secretory products and exsheathing fluid of the infective (L3) larva of Necator americanus
81. Cysteinyl proteinases of Schistosoma mansoni eggs: Purification and partial characterization
82. The Toxoplasma adhesive protein MIC2 is proteolytically processed at multiple sites by two parasite-derived proteases
83. Caspase-dependent apoptosis during infection with Cryptosporidium parvum
84. Maturation of giardiavirus capsid protein involves posttranslational proteolytic processing by a cysteine protease
85. Cathepsin B-like activity predominates over cathepsin L-like activity in adult Schistosoma mansoni and S. japonicum
86. Pig kidney legumain: An asparaginyl endopeptidase with restricted specificity
87. Multiple functional proteins are produced by cleaving Asn-Gln bonds of a single precursor by vacuolar processing enzyme
88. Cysteine proteases of Trichomonas vaginalis degrade secretory leukocyte protease inhibitor
89. Iron mediates Trichomonas vaginalis resistance to complement lysis
90. Isolation of lmcpc, a gene encoding a Leishmania mexicana cathepsin-B- like cysteine proteinase
91. Leishmania mexicana cysteine proteinase-deficient mutants have attenuated virulence for mice and potentiate a Th1 response
92. Plasma leakage induced in postcapillary venules by the major cysteine- proteinase from Trypanosoma cruzi and its modulation by H1-blocker mepyramine
93. A comparative study of allergenic and potentially allergenic enzymes from Dermatophagoides pteronyssinus, D. farinae and Euroglyphus maynei
94. Unlocking the allergenic structure of the major house dust miteallergen Der f 2 by elimination of key intramolecular interactions
95. Neutralization of the activity of a Fasciola hepatica cathepsin L proteinase by anti-cathepsin L antibodies
96. Monoclonal antibodies against Dermatophagoides group I allergens as pseudo-cystatins blocking the catalytic site of cysteine proteinases
97. Calpain is the target antigen of a Th1 clone that transfers protective immunity against Schistosoma mansoni
98. Induction of protective immunity in cattle against infection with Fasciola hepatica by vaccination with cathepsin L proteinases and with hemoglobin
99. Molecular cloning and characterization of gut-derived cysteine proteinases associated with a host protective extract from Haemonchus contortus
100. Anti-malarial drug development using models of enzyme structure
101. Design and synthesis of dipeptidyl alpha, 'beta'-epoxy ketones, potent irreversible inhibitors of the cysteine protease cruzain
102. Trypanocidal effect of cysteine protease inhibitors in vitro and in vivo in experimental Chagas disease
103. In vitro evaluation of the disposition of A novel cysteine protease inhibitor
104. Potent dipeptidylketone inhibitors of the cysteine protease cathepsin K
105. Rapid and general profiling of protease specificity by using combinatorial fluorogenic substrate libraries
106. Substrate binding and sequence preference of the proteasome revealed by active-site-directed affinity probes
107. In vitro evaluation of the disposition of a novel cysteine protease